Biomarkers for Rare Non-Oncological Diseases Summit
November 10 - 11, 2020 - MS USHanson Wade
info@hansonwade.com
Phone:+16174554188
Free to Attend for Drug Developers, Researchers and Academics! Drawing on a multitude of disease areas spanning neurology, cardiology, metabolic, renal, inflammatory and more, the meeting combines a range of perspectives and experiences for unparalleled learning opportunities. With 2 days of in-depth case studies, interactive panel discussions, dedicated Q+A time and valuable networking opportunities, you can walk away with improved end-to-end strategies from early biomarker validation to effective clinical trials and enabling successful regulatory, payer and commercial discussions. Improving early validation, patient selection, clinical utility demonstration and reducing diagnostic timelines is critical to closing the gap on unmet clinical need for defined patient groups. Built exclusively for biopharma, researchers and diagnostic developers, this meeting focuses specifically on the advancement of precision medicine in rare and defined patient groups. You can join fellow discovery, translational, clinical and commercial teams all dedicated to tackling the field’s most pressing challenges to radically improve patient outcomes and quality of care.